CAF Accepting 2011-2012 Research Grant Applications
September 24, 2010 – The Cooley’s Anemia Foundation is accepting applications for the following:
SUPPORT FOR ONGOING CLINICAL RESEARCH IN THALASSEMIA
The Cooley’s Anemia Foundation invites national and international applications for 2011-2012 grants to support ongoing clinical research projects in Thalassemia. The goal of this initiative is to support investigators from all disciplines and backgrounds (MD, RN, PhD, MPH, MSW or other disciplines) with their ongoing clinical projects to address one or more of the following areas impacting patients with thalassemia: including but not limited to fertility, pregnancy and family planning; quality of life/psychosocial; burden of disease, cardiac issues and iron overload. The stipend will be $40,000 annually with possibility of one year renewal upon submission of a renewal application and approval by the Foundation’s Scientific Review Committee and Board of Directors. This level of funding would be appropriate for support of innovative small-scale pilot studies, observational trials, or ancillary support for ongoing interventional studies (for example support of a trainee joining an existing trial, or new biological endpoint analyses for an existing trial). In the case of ancillary studies, investigators should clearly document the support for the parent trial in their “other support” declarations. Junior and senior faculty are eligible; fellows and trainees are not eligible. Investigators must interact directly with patients or patient-related data. Awards will be announced in June 2011.
The completed application is due Monday, February 7, 2011. Application forms and instructions for this grant can be downloaded by clicking here.
GENE RESEARCH IN THALASSEMIA TRANSLATIONAL GRANT AWARD
The purpose of this initiative is to speed the application of recent translational advances in gene therapy to clinical trials. The Foundation recognizes that there are many key areas worthy of support in the search for a cure for thalassemia with cell therapy and gene therapy. While several funding mechanisms are available for a range of studies on vector development, proof of concept studies in animal models, and transplantation, there remains a funding gap for launching human trials. Both phase I (safety) and phase II (efficacy) trials are eligible for support. Funding and candidate eligibility: Total funding of up to $60,000 per year will be available (including indirect costs of 8%). With satisfactory evidence of progress the grant may be renewed for a second year. The research may not be conducted at a for-profit laboratory. Because the purpose of the support is to facilitate launch of clinical trials, eligible studies proposed for this RFA must be accompanied by a realistic timeline of progress to human trials. The Foundation recognizes that this timeline can be long. Applicants should state explicitly the status of their proposed trials, for example whether the trial has been approved by the recombinant DNA Advisory Committee (RAC), or Food and Drug Administration (or equivalent processes at non-US sites), or whether review meetings at regulatory agencies have been scheduled. Awards will be announced in June 2011.
The completed application is due Monday February 7, 2011. Application forms and instructions for this grant can be downloaded by clicking here.
RESEARCH FELLOWSHIPS
The Cooley’s Anemia Foundation invites national and international applications for 2011-2012 Research Fellowships. Postdoctoral and junior faculty members investigating clinical or basic research related to thalassemia are eligible. Applications studying iron overload, iron chelation, methods of non-invasive iron measurement, quality of life, hepatitis C, osteoporosis, fertility, bone marrow transplantation and gene therapy are encouraged. Postdoctoral fellows should hold MD, PhD or equivalent degrees and require sponsorship by a faculty mentor. Junior faculty applicants should not have held the rank of Assistant Professor for more than 5 years and must not have already received R-01 level support. Stipends will be $32,500 annually with possibility of a one year renewal upon submission of a renewal application and approval by the Foundation’s Scientific Review Committee and Board of Directors. Successful postdoctoral fellows are expected to use the funds for salary support, whereas junior faculty applicants may use funds for salary or non-salary research support. Awards will be announced in June 2011.
The completed application is due Monday, February 7, 2011. Application forms and instructions for fellowships can be downloaded by clicking here.
For further information, please contact:
Cooley’s Anemia Foundation
330 Seventh Avenue #200 * New York, NY 10001
800 522 7222
info@cooleysanemia.org